N-acetylcysteine for sepsis and systemic inflammatory response in adults

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 12, 2012, Pages

  Szakmany, Tamas ^a   Hauser, Balázs ^b   Radermacher, Peter ^c  

^a ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT;

ADULT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ACETYLCYSTEINE; ADULT; ANTIOXIDANTS; HUMANS; INJECTIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 84873020078     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006616.pub2     Document Type: Article

References (113)

1. Andersen LW, Thiis J, Kharazmi A, Rygg I. The role of N-acetylcystein administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 2005;10:21-6. [DOI: 10.1177/026765919501000105]x-wiley/crsRef/9769182
2. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 1997;112:164-72. [PUBMED: 9228372]x-wiley/crsRef/9769184
3. Bromley PN, Cottam SJ, Hilmi I, Tan KC, Heaton N, Ginsburg R, et al. Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation. British Journal of Anaesthesia 1995;75(3):352-4. [PUBMED: 7547057]x-wiley/crsRef/9769186
4. Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA 2005;294(3):342-50. [PUBMED: 16030279]x-wiley/crsRef/9769188
5. Burns KE, Priestap F, Martin C. N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomized trial. Clinical Nephrology 2010;74(4):323-6. x-wiley/crsRef/9769190
6. Charunwatthana P, Abul Faiz M, Ruangveerayut R, Maude RJ, Rahman MR, Roberts LJ 2nd, et al. N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Critical Care Medicine 2009;37(2):516-22. [DOI: 10.1097/CCM.0b013e3181958dfd]x-wiley/crsRef/9769192
7. Csontos C, Rezman B, Foldi V, Bogar L, Drenkovics L, Röth E, et al. Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn. Burns 2011;38(3):428-37. [DOI: doi:10.1016/j.burns.2011.09.011; PUBMED: 21978796]x-wiley/crsRef/9769194
8. De Backer WA, Amsel B, Jorens PG, Bossaert L, Hiemstra PS, van Noort P, et al. N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid. Intensive Care Medicine 1996;22(9):900-8. [PUBMED: 8905424]x-wiley/crsRef/9769196
9. Domenighetti G, Suter PM, Schaller MD, Ritz R, Perret C. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. Journal of Critical Care 1997;12(4):177-82. [PUBMED: 9459113]x-wiley/crsRef/9769198
10. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. The Journal of Thoracic and Cardiovascular Surgery 2007;133:7-12. [PUBMED: 17198774]x-wiley/crsRef/9769200
11. Emet S, Memis D, Pamukçu Z. The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis. Critical Care 2004;8(4):229-30. [DOI: 10.1186/cc2866]x-wiley/crsRef/9769202
12. Eren N, Cakir O, Oruc A, Kaya Z, Erdinc L. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 2003;18(6):345-50. [DOI: 10.1191/0267659103pf696oa]x-wiley/crsRef/9769204
13. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S, et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Critical Care Medicine 2007;35(5):1324-31. [DOI: 10.1097/01.CCM.0000261887.69976.12]x-wiley/crsRef/9769206
14. Hilmi IA, Peng, Z, Planinsic RM, Damian D, Dai F, Tyurina YY, Kagan VE, Kellum JA. N-acetylcysteine does not prevent hepatorenal ischaemia–reperfusion injury in patients undergoing orthotopic liver transplantation. Nephrology, Dialysis, Transplantation 2010;25:2328-2333. [DOI: 10.1093/ndt/gfq077]x-wiley/crsRef/9769208
15. Hynninen MS, Niemi TT, Pöyhiä R, Raininko EI, Salmenperä MT, Lepäntalo MJ, et al. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. Anesthesia and Analgesia 2006;102(6):1638-45. [DOI: 10.1213/01.ANE.0000219590.79796.66]x-wiley/crsRef/9769210
16. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Critical Care Medicine 1992;20(7):918-23. [PUBMED: 1617983]x-wiley/crsRef/9769212
17. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991;303(6809):1026-9. [PUBMED: 1954453]x-wiley/crsRef/9769214
18. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009;137(3):856-64. [DOI: 10.1053/j.gastro.2009.06.006]x-wiley/crsRef/9769216
19. Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM Jr. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. Nephrology, Dialysis, Transplantation 2006;21(7):1863-9. [DOI: 10.1093/ndt/gfl079; PUBMED: 16522657]x-wiley/crsRef/9769218
20. Molnár Z, Shearer E, Lowe D. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Critical Care Medicine 1999;27(6):1100-4. [PUBMED: 10397212]x-wiley/crsRef/9769220
21. Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, et al. The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respiratory Medicine 2009;103(3):434-41. [PUBMED: 18993042]x-wiley/crsRef/9769222
22. Orhan G, Yapici N, Yuksel M, Sargin M, Senay S, Yalcin AS, et al. Effects of N-acetylcysteine on myocardial ischemia–reperfusion injury in bypass surgery. Heart and Vessels 2006;21:42-7. [PUBMED: 16440148]x-wiley/crsRef/9769224
23. Ortolani O, Conti A, De Gaudio AR, Masoni M, Novelli G. Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock 2000;13(1):14-8. [PUBMED: 10638663]x-wiley/crsRef/9769226
24. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, et al. N-acetylcysteine for prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. European Heart Journal 2008;29:625-31. [DOI: 10.1093/eurheartj/ehn011; PUBMED: 18263874]x-wiley/crsRef/9769228
25. Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Critical Care Medicine 2003;31(11):2474-8. [DOI: 10.1097/01.CCM.0000089945.69588.18; PUBMED: 14605526]x-wiley/crsRef/9769230
26. Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Critical Care Medicine 1996;24(8):1302-10. [PUBMED: 8706483]x-wiley/crsRef/9769232
27. Peker O, Peker T, Erdogan D, Ozaydin M, Kapan S, Sutcu R, et al. Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. The Journal of Cardiovascular Surgery 2008;49(4):527-31. [PUBMED: 18665117]x-wiley/crsRef/9769234
28. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, et al. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Critical Care Medicine 2000;28(12):3799-807. [PUBMED: 11153617]x-wiley/crsRef/9769236
29. Ristikankare A, Kuitunen T, Kuitunen A, Uotila L, Vento A, Suojaranta-Ylinen R, et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. British Journal of Anaesthesia 2006;97(5):611-6. [DOI: 10.1093/bja/ael224; PUBMED: 16914459]x-wiley/crsRef/9769238
30. Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Critical Care Medicine 2008;36(1):81-6. [PUBMED: 18090169]x-wiley/crsRef/9769240
31. Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?. Chest 1998;113(6):1616-24. [PUBMED: 9631802]x-wiley/crsRef/9769242
32. Spapen HD, Diltoer MW, Nguyen DN, Hendrickx I, Huyghens LP. Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study. Chest 2005;127(4):1413-9. [PUBMED: 15821223]x-wiley/crsRef/9769244
33. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, et al. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Critical Care Medicine 1994;22(11):1738-46. [PUBMED: 7956276]x-wiley/crsRef/9769246
34. Spies C, Giese C, Meier-Hellmann A, Specht M, Hannemann L, Schaffartzik W, et al. [The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients] [Einflus der prophylaktischen gabe von N-Azetylzystein auf klinische indikatoren der gewebeoxygenierung unter hyperoxie bei kardialen rizikopatienten]. Anaesthesist 1996;45(4):343-50. [PUBMED: 8702052]x-wiley/crsRef/9769248
35. Steib A, Freys G, Collin F, Launoy A, Mark G, Boudjema K. Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?. Liver Transplantation and Surgery 1998;4(2):152-7. [PUBMED: 9516568]x-wiley/crsRef/9769250
36. Sucu N, Cinel I, Unlu A, Aytacoglu B, Tamer L, Kocak Z, et al. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surgery Today 2004;34:237-42. [DOI: 10.1007/s00595-003-2699-8; PUBMED: 14999536]x-wiley/crsRef/9769252
37. Suter PM, Domenighetti G, Schaller MD, Laverrière MC, Ritz R, Perret C. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 1994;105(1):190-4. [PUBMED: 8275731]x-wiley/crsRef/9769254
38. Szakmany T, Marton S, Molnar Z. Lack of effect of prophylactic N-acetylcysteine on postoperative organ dysfunction following major abdominal tumour surgery: a randomized, placebo-controlled, double-blinded clinical trial. Anaesthesia and Intensive Care 2003;31(3):267-71. [PUBMED: 12879670]x-wiley/crsRef/9769256
39. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. The Journal of Thoracic and Cardiovascular Surgery 2003;126(5):1513-20. [DOI: 10.1016/S0022-5223(03)00968-1; PUBMED: 14666027]x-wiley/crsRef/9769258
40. Walsh TS, Hopton P, Philips BJ, Mackenzie SJ, Lee A. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 1998;27(5):1332-40. [PUBMED: 9581688]x-wiley/crsRef/9769260
41. Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Canadian Journal of Anaesthesia 2007;54(11):872-81. [PUBMED: 17975231]x-wiley/crsRef/9769262
42. Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, et al. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. American Heart Journal 2008;155(6):1143-9. [DOI: 10.1016/j.ahj.2008.01.013; NCT00211653; PUBMED: 18513531]x-wiley/crsRef/9769264
43. Agustí AG, Togores B, Ibañez J, Raurich JM, Maimó A, Bergada J, et al. Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia. The European Respiratory Journal 1997;10(9):1962-6. [DOI: 10.1183/09031936.97.10091962]x-wiley/crsRef/9769266
44. Barr LF, Kolodner K. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Critical Care Medicine 2008;36(5):1427-35. [PUBMED: 18434903]x-wiley/crsRef/9769268
45. Csontos C, Rezman B, Foldi V, Bogar L, Bognar Z, Drenkovics L, Röth E, Weber G, Lantos J. Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury. Burns 2011;37(3):453-64. [DOI: 10.1016/j.burns.2010.10.008; PUBMED: 21131132]x-wiley/crsRef/9769270
46. De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, et al. N-acetylcysteine replenishes glutathione in HIV infection. European Journal of Clinical Investigation 2000;30(10):915-29. [PUBMED: 11029607]x-wiley/crsRef/9769272
47. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Critical Care Medicine 1997;25(2):236-42. [PUBMED: 9034257]x-wiley/crsRef/9769274
48. Fischer UM, Tossios P, Mehlhorn U. Renal protection by radical scavenging in cardiac surgery patients. Current Medical Research and Opinion 2005;21(8):1161-4. [PUBMED: 16083524]x-wiley/crsRef/9769276
49. Fraga CM, Tomasi CD, Biff D, Topanotti MFL, Felisberto F, Vuolo F, et al. The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: A randomized controlled trial. Journal of Clinical Pharmacology 2011;Nov 1:Epub ahead of print. [PUBMED: 22045831]x-wiley/crsRef/9769278
50. Haase M, Haase-Fielitz A, Ratnaike S, Reade MC, Bagshaw SM, Morgera S, et al. N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrology, Dialysis, Transplantation 2008;23(5):1581-7. [DOI: 10.1093/ndt/gfm818]x-wiley/crsRef/9769280
51. Heller AR, Groth G, Heller SC, Breitkreutz R, Nebe T, Quintel M, et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Critical Care Medicine 2001;29(2):272-6. [PUBMED: 11246305]x-wiley/crsRef/9769282
52. Jepsen S, Klaerke A, Nielsen PH, Nielsen ST, Simonsen O. Systemic administration of N-acetylcysteine has no effect on postoperative lung function following elective upper laparotomy in lung healthy patients. Acta Anaesthesiologica Scandinavica 1989;33(3):219-22. [PUBMED: 2658458]x-wiley/crsRef/9769284
53. Köksal H, Rahman A, Burma O, Halifeoglu I, Bayar MK. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery. Anadolu Kardiyoloji Dergisi: AKD = The Anatolian Journal of Cardiology 2008;8(6):437-43. [PUBMED: 19103540]x-wiley/crsRef/9769286
54. Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Critical Care Medicine 2007;35(2):435-41. [DOI: 10.1097/01.CCM.0000253816.83011.DB]x-wiley/crsRef/9769288
55. Koramaz I, Pulathan Z, Usta S, Karahan SC, Alver A, Yaris E, et al. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. Annals of Thoracic Surgery 2006;81(2):613-8. [DOI: 10.1016/j.athoracsur.2005.08.013]x-wiley/crsRef/9769290
56. Kurian GA, Paddikkala J. N-acetylcysteine and magnesium improve biochemical abnormalities associated with myocardial ischaemic reperfusion in South Indian patients undergoing coronary artery bypass grafting: a comparative analysis. Singapore Medical Journal 2010;51(5):381-8. x-wiley/crsRef/9769292
57. Laurent T, Markert M, Feihl F, Schaller MD, Perret C. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Chest 1996;106(1):163-6. [PUBMED: 8549180]x-wiley/crsRef/9769294
58. Lawlor DK, Moist L, DeRose G, Harris KA, Lovell MB, Kribs SW, et al. Prevention of contrast-induced nephropathy in vascular surgery patients. Annals of Vascular Surgery 2007;21(5):593-7. [PUBMED: 17823041]x-wiley/crsRef/9769296
59. Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World Journal of Gastroenterology: WJG 2006;12(23):3751-5. [PUBMED: 16773694]x-wiley/crsRef/9769298
60. Molnar Z, MacKinnon KL, Shearer E, Lowe D, Watson ID. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients. Intensive Care Medicine 1998;24(3):230-5. [PUBMED: 9565804]x-wiley/crsRef/9769300
61. Molnar Z, Szakmany T, Koszegi T. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial. Intensive Care Medicine 2003;29(5):749-55. [PUBMED: 12682719]x-wiley/crsRef/9769302
62. Najafi A, MojtahedzadehM, Mahmoodpoor A, Aghamohammadi M, Ahmadi A, Nahreini S, et al. Effect of N-acetylcysteine on microalbuminuria in patients with acute respiratory distress syndrome. Archives of Medical Science 2009;5(3):408-14. x-wiley/crsRef/9769304
63. Niemi TT, Munsterhjelm E, Pöyhiä R, Hynninen MS, Salmenperä MT. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagulation & Fibrinolysis 2006;17(1):29-34. [PUBMED: 16607076]x-wiley/crsRef/9769306
64. Ortolani O, Conti A, De Gaudio AR, Moraldi E, Cantini Q, Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. American Journal of Respiratory Critical Care Medicine 2000;161(6):1907-11. [PUBMED: 10852765]x-wiley/crsRef/9769308
65. Reinhart K, Spies CD, Meier-Hellmann A, Bredle DL, Hannemann L, Specht M, et al. N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. American Journal of Respiratory and Critical Care Medicine 1995;151:773-9. [PUBMED: 7881669]x-wiley/crsRef/9769310
66. Sahib AS, Al-Jawad FH, Alkaisy AA. Effect of antioxidants on the incidence of wound infection in burn patients. Annals of Burns and Fire Disasters 2010;23(4):199-205. [PUBMED: 21991225]x-wiley/crsRef/9769312
67. Saricaoglu F, Dal D, Salman AE, Atay OA, Doral MN, Salman MA, et al. Effect of low-dose N-acetyl-cysteine infusion on tourniquet-induced ischaemia-reperfusion injury in arthroscopic knee surgery. Acta Anaesthesiologica Scandinavica 2005;49(6):847-51. [PUBMED: 15954970]x-wiley/crsRef/9769314
68. Siriwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 2007;56(10):1439-44. [PUBMED: 17356040]x-wiley/crsRef/9769316
69. Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, et al. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Human & Experimental Toxicology 2007;26(9):697-703. [PUBMED: 17984140]x-wiley/crsRef/9769318
70. Spies C, Reinhart K, Witt I, Walensky C, Hannemann L, Specht M, et al. Influence of N-acetylcysteine on O2 consumption and gastric intramucosal pH in septic patients. Critical Care Medicine 1993;21 Suppl 4:183. x-wiley/crsRef/9769320
71. Szakmány T, Tóth I, Márton S, Molnár Z. [Effect of prophylactic N-acetylcysteine on postoperative organ dysfunction and inflammatory markers after major abdominal surgery for cancer. Prospective, randomized, double-blind, placebo-controlled clinical trial] [Profilaktikus N-acetylcysteine kezeles hatasa a posztoperativ szervdiszfunkciora es gyulladasos markerek szintjere kiterjesztett hasi tumorsebeszeti beavatkozasok utan. Prospektiv, randomizalt, kettos-vak, placebo kontrolalt klinikai tanulmany]. Magyar Sebészet 2002;55(6):369-74. [PUBMED: 12616822]x-wiley/crsRef/9769322
72. Wijeysundera DN, Karkouti K, Rao V, Granton JT, Chan CT, Raban R, et al. N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Critical Care Medicine 2009;37(6):1929-34. [PUBMED: 19384218]x-wiley/crsRef/9769324
73. Zingg U, Hofer CK, Seifert B, Metzger U, Zollinger A. High dose N-acetylcysteine to prevent pulmonary complications in partial or total transthoracic esophagectomy: results of a prospective observational study. Diseases of the Esophagus 2007;20(5):399-405. [PUBMED: 17760653]x-wiley/crsRef/9769326
74. Adabag AS, Ishani A, Bloomfield HE, Ngo AK, Wilt TJ. Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. European Heart Journal 2009;30(15):1910-7. [PUBMED: 19282300]
75. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biology & Medicine 1989;6:593-7. [MEDLINE: 2546864]
76. Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. European Journal of Cardiothoracic Surgery 2009;35(3):521-7. [PUBMED: 19147369]
77. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55. [MEDLINE: 1303622]
78. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Critical Care Medicine 1996;24:1179-83. [MEDLINE: 8674332]
79. Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C. The role of oxidative stress in adult critical care. Free Radical Biology & Medicine 2006;40(3):398-406. [DOI: 10.1016/j.freeradbiomed.2005.10.054; PUBMED: 16443154]
80. Cross CE, van Asbeck BS, Halliwell B. More antioxidants in sepsis: still paved with uncertainties. Critical Care Medicine 2006;34(2):569-571. [PUBMED: 16424756]
81. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphic test. BMJ 1997;315:629-34. [MEDLINE: 9310563]
82. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Medicine 2007;33(4):606-18. [DOI: 10.1007/s00134-006-0517-7; PUBMED: 17323051]
83. Gotzsche PC. Why we need a broad perspective on meta-analysis.It may be crucially important for patients. BMJ 2000;321(7261):585-6. [PUBMED: 10977820]
84. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Critical Care Medicine 1995;23:646-51. [MEDLINE: 7712754]
85. Harman LS, Mottley C, Mason RP. Free radical metabolites of L-cysteine oxidation. The Journal of Biological Chemistry 1984;259:5606-11. [PUBMED: 6325443]
86. Henderson A, Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: potential new use for an old drug. The Annals of Pharmacotherapy 1994;28:1086-8. [MEDLINE: 7803886]
87. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med 2002;21:1539-58. [DOI: 10.1002/sim.1186]
88. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from http://www.cochrane-handbook.org: The Cochrane Collaboration, 2011.
89. Ho KM, Morgan DJ. Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. American Journal of Kidney Diseases 2009;53(1):33-40. [DOI: 10.1053/j.ajkd.2008.05.019; PUBMED: 18649982]
90. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319(7211):670-4. [PUBMED: 10480822]
91. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13-23. [DOI: 10.1186/1471-2288-5-13]
92. Hsu BG, Yang FL, Lee RP, Peng TC, Harn HJ, Chen HI. N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. Journal of Biomedical Science 2004;11:152-62. [MEDLINE: 14966365]
93. Kiefer P, Vogt J, Radermacher P. From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine. Critical Care Medicine 2000;28:3935-6. [MEDLINE: 11153640]
94. Koch T, Heller S, Heissler S, Breil I, Schiefer HG, van Ackern K, et al. Effects of N-acetylcysteine on bacterial clearance. European Journal of Clinical Investigation 1996;26:884-92. [MEDLINE: 8911862]
95. Magder S. Reactive oxygen species: toxic molecules or spark of life?. Critical Care 2006;10(1):208. [DOI: 10.1186/cc3992; PUBMED: 16469133]
96. Molnár Z. N-acetylcysteine as the magic bullet: too good to be true. Critical Care Medicine 2008;36(2):645-6. [PUBMED: 18216629]
97. Naughton F, Wijeysundera D, Karkouti K, Tait G, Beattie WS. N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis. Canadian Journal of Anaesthesia 2008;55(12):827-35. [PUBMED: 19050086]
98. Nigwekar SU, Kandula P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Annals of Thoracic Surgery 2009;87(1):139-47. [PUBMED: 19101287]
99. Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG. Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Medicine 1991;17:40-4. [MEDLINE: 1645378]
100. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Annals of Internal Medicine 1992;116:78-84. [MEDLINE: 1530753]
101. Peristeris P, Clark BD, Gatti S, Faggioni R, Mantovani A, Mengozzi M, et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cellular Immunology 1992;140:390-9. [MEDLINE: 1544168]
102. Pinsky MR. Antioxidant therapy for severe sepsis: promise and perspective. Critical Care Medicine 2003;31:2697-8. [MEDLINE: 14605544]
103. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. European Journal of Clinical Pharmacology 1989;37(5):501-6. [PUBMED: 2598989]
104. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992;339:466-9. [MEDLINE: 1346826]
105. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
106. Rücker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine 2008;27(5):746-63. [PUBMED: 17592831]
107. Schmidt H, Schmidt W, Müller T, Böhrer H, Gebhard MM, Martin E. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Critical Care Medicine 1997;25:558-63. [MEDLINE: 9187607]
108. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H. Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances. Intensive Care Medicine 1998;24(9):967-72.
109. Spapen H. N-acetylcysteine in clinical sepsis: a difficult marriage. Critical Care 2004;8(4):229-30.
110. Vassilev D, Hauser B, Bracht H, Iványi Z, Schoaff M, Asfar P, et al. Systemic, pulmonary, and hepatosplanchnic effects of N-acetylcysteine during long-term porcine endotoxemia. Critical Care Medicine 2004;32(2):525-32. [PUBMED: 14758174]
111. Yang R, Miki K, He X, Killeen ME, Fink MP. Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity. Critical Care 2009;13(2):R55. [DOI: 10.1186/cc7782; PUBMED: 19358737]
112. Zhang H, Spapen H, Benlabed M, Nguyen DN, Buurman WA, Vincent JL. Pentoxifylline improves the tissue oxygen extraction capabilities during endotoxic shock. Shock 1994;2:90-7. [MEDLINE: 7728587]
113. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL. Protective effects of N-acetyl-L-cysteine in endotoxemia. The American Journal of Physiology 1994;266:H1746-54. [MEDLINE: 8203575]